AAAAAA

   
Results: 1-25 | 26-50 | 51-70 |
Results: 51-70/70

Authors: Redlich, A Perka, C Schultz, O Spitzer, R Haupl, T Burmester, GR Sittinger, M
Citation: A. Redlich et al., Bone engineering on the basis of periosteal cells cultured in polymer fleeces, J MAT S-M M, 10(12), 1999, pp. 767-772

Authors: Priem, S Franz, JK Rittig, MG Burmester, GR Krause, A
Citation: S. Priem et al., New avenues in the diagnosis of Lyme borreliosis using molecular biology, ZBL BAKT, 289(5-7), 1999, pp. 681-686

Authors: Sittinger, M Perka, C Schultz, O Haupl, T Burmester, GR
Citation: M. Sittinger et al., Joint cartilage regeneration by tissue engineering, Z RHEUMATOL, 58(3), 1999, pp. 130-135

Authors: Keyszer, G Lambiri, I Nagel, R Keysser, C Keysser, M Gromnica-Ihle, E Franz, J Burmester, GR Jung, K
Citation: G. Keyszer et al., Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers, J RHEUMATOL, 26(2), 1999, pp. 251-258

Authors: Dorffel, Y Latsch, C Stuhlmuller, B Schreiber, S Scholze, S Burmester, GR Scholze, J
Citation: Y. Dorffel et al., Preactivated peripheral blood monocytes in patients with essential hypertension, HYPERTENSIO, 34(1), 1999, pp. 113-117

Authors: Baerwald, CGO Wahle, M Ulrichs, T Jonas, D von Bierbrauer, A von Wichert, P Burmester, GR Krause, A
Citation: Cgo. Baerwald et al., Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis, IMMUNOBIOL, 200(1), 1999, pp. 77-91

Authors: Kreklau, B Sittinger, M Mensing, MB Voigt, C Berger, G Burmester, GR Rahmanzadeh, R Gross, U
Citation: B. Kreklau et al., Tissue engineering of biphasic joint cartilage transplants, BIOMATERIAL, 20(18), 1999, pp. 1743-1749

Authors: Franz, JK Priem, S Rittig, MG Burmester, GR Krause, A
Citation: Jk. Franz et al., Studies on the pathogenesis and treatment of Lyme arthritis, WIEN KLIN W, 111(22-23), 1999, pp. 981-984

Authors: Genth, E Burmester, GR Gross, WL Marker-Hermann, E Ringe, JD
Citation: E. Genth et al., Rheumatology, INTERNIST, 40(4), 1999, pp. 401-406

Authors: Grunewald, T Burmester, GR Schuler-Maule, W Hiepe, F Buttgereit, F
Citation: T. Grunewald et al., Anti-phospholipid antibodies and CD5(+) B cells in HIV infection, CLIN EXP IM, 115(3), 1999, pp. 464-471

Authors: Buttgereit, F Brand, MD Burmester, GR
Citation: F. Buttgereit et al., Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: A novel glucocorticoid hierarchy, BIOCH PHARM, 58(2), 1999, pp. 363-368

Authors: Backhaus, M Kamradt, T Sandrock, D Loreck, D Fritz, J Raber, H Hamm, B Burmester, GR Bollow, M
Citation: M. Backhaus et al., Arthritis of the finger joints - A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging, ARTH RHEUM, 42(6), 1999, pp. 1232-1245

Authors: Blass, S Schumann, F Hain, NAK Engel, JM Stuhlmuller, B Burmester, GR
Citation: S. Blass et al., p205 is a major target of autoreactive T cells in rheumatoid arthritis, ARTH RHEUM, 42(5), 1999, pp. 971-980

Authors: Feist, E Kuckelkorn, U Dorner, T Donitz, H Scheffler, S Hiepe, F Kloetzel, PM Burmester, GR
Citation: E. Feist et al., Autoantibodies in primary Sjogren's syndrome are directed against proteasomal subunits of the alpha and beta type, ARTH RHEUM, 42(4), 1999, pp. 697-702

Authors: Hansen, A Feist, E Hiepe, F Burmester, GR Scholze, J
Citation: A. Hansen et al., Diffuse infiltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1, ARTH RHEUM, 42(3), 1999, pp. 578-580

Authors: Buttgereit, F Burmester, GR Wehling, M
Citation: F. Buttgereit et al., Further thoughts on the immunomodulatory role of glucocorticoids: comment on the article by Buttgereit et al - Reply, ARTH RHEUM, 42(2), 1999, pp. 395-396

Authors: Blass, S Engel, JM Burmester, GR
Citation: S. Blass et al., The immunologic homunculus in rheumatoid arthritis, ARTH RHEUM, 42(12), 1999, pp. 2499-2506

Authors: Furst, DE Breedveld, FC Burmester, GR Crofford, L Emery, P Feldman, M Kalden, JR Kavanaugh, A Keystone, E Lipsky, EP Maini, RN Moreland, L Smolen, JS Van de Putte, L Smolen, JS Van de Putte, L Vischer, T Weinblatt, M Weissman, M
Citation: De. Furst et al., Access to disease modifying treatments for rheumatoid arthritis patients, ANN RHEUM D, 58, 1999, pp. 129-130

Authors: Keyszer, G Lambiri, I Keysser, M Keysser, C Nagel, R Burmester, GR Jung, K
Citation: G. Keyszer et al., Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity, Z RHEUMATOL, 57(6), 1998, pp. 392-398

Authors: Franz, JK Pap, T Muller-Ladner, U Gay, RE Burmester, GR Gay, S
Citation: Jk. Franz et al., T cell-independent joint destruction, PROG INFLAM, 1998, pp. 55-74
Risultati: 1-25 | 26-50 | 51-70 |